Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2003 Mar;80(1):115–126. doi: 10.1093/jurban/jtg115

Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of porto alegre, Brazil

Flavio Pechansky 1,2,✉, Lisia von Diemen 1,2, Felix Kessler 1,2, Vania Hirakata 1,2, David Metzger 1,2, George E Woody 1,2
PMCID: PMC3456113  PMID: 12612101

Abstract

A sample of 193 southern Brazilian inner-city cocaine abusers was studied to assess the prevalence of human immunodeficiency virus (HIV) infection. Following the exclusion of those who were seropositive from the intake sample, a cohort of 138 HIV-negative cocaine abusers was followed for 18 months to assess seroincidence rates and the associated characteristics. HIV status, drug use, sexual risk behaviors, and presence and severity of medical and psychiatric symptoms were collected at intake using a Brazilian version of the Risk Assessment Battery, the Addiction Severity Index (ASI), Symptom Check List-90 (SCL-90), and Beck Depression Inventory (BDI): this was repeated at 6-, 12-, and 18-month intervals. The overall seroprevalence was 28,5%, and the variables associated with HIV seropositivity were age older than 25 years, being single, having less than 8 years of education, and having injected cocaine at least once. Although follow-up procedures were difficult to implement due to sample characteristics, we obtained data from 82,6% of the participants for at least one follow-up and for 57% at all follow-up windows. Most participants showed high scores on the Beck Depression Inventory (mean of 20.6±13.9) and Symptom Check List-90 (mean of 106.4±91.9). There were 8 seroconversions in the 18-month period, yielding an incidence rate of 5.03/100 (confidence interval [CI] 2.2–9.7) person-years at risk. None of the seroconverters reported recent cocaine injection, and only 14.5% of the overall sample reported ever injecting cocaine, which suggests that another significant mode of transmission via sexual behavior should be considered as well. Each of these findings has important implications for the design of preventive interventions.

Keywords: Cocaine abuse, Drug abuse, HIV/AIDS, Seroincidence, Seroprevalence

Full Text

The Full Text of this article is available as a PDF (85.8 KB).

References

  • 1.United Nations Drug Control Programme, 1999. World situation with regard to drug abuse—note by the Secretariat. Available at: http://www.undcp.org/pdf/document_1999-12-23_2.pdf.
  • 2.Brazilian Ministry of Health. Boletim epidemiológico AIDS, Tabela IV—Distribuição dos casos de aids, segundo ano de diagnóstico e categoria de exposição hierarquizada, Brasil, 1980–2000, 2001. Available at: http://www.aids.gov.br/sitebol.
  • 3.WHO Collaborative Study Group An international comparative study of HIV prevalence and risk behavior among drug injectors in 13 cities. Bull Narcotics. 1993;45:19–46. [PubMed] [Google Scholar]
  • 4.Nappo SA, Noto AR, Galduróz JC, Carlini EA. Centro Brasileiro de Informações sobre Drogas Psicotrópicas, Boletim no. 44. Março, Abril e Maio de 2000. cebrid@psicobio.epm.br.
  • 5.Pechansky F, Inciardi JÁ, Surratt H, et al. Estudo sobre as características de usuários de drogas injetáveis que buscam atendimento em Porto Alegre. Rev Bras Psiquiatria. 2000;22(4):164–171. [Google Scholar]
  • 6.Pechansky F, Diemen L. Homens e mulheres usuários de drogas: semelhanças e diferenças na exposição ao virus HIV em Porto Alegre. Revista da ABEAD. 1998;1/2:15–25. [Google Scholar]
  • 7.Pechansky F, Diemen L, Genro V. Presença de situa ções de risco para a transmissão do HIV em usuários de drogas náo-injetáveis. Rev Psiq Clin. 2001;28(3):120–125. [Google Scholar]
  • 8.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
  • 9.McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33. doi: 10.1097/00005053-198001000-00006. [DOI] [PubMed] [Google Scholar]
  • 10.McLellan AT, Kushner H, Metzger DS, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213. doi: 10.1016/0740-5472(92)90062-S. [DOI] [PubMed] [Google Scholar]
  • 11.Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self report scale. Br J Psychiatry. 1976;128:280–289. doi: 10.1192/bjp.128.3.280. [DOI] [PubMed] [Google Scholar]
  • 12.Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  • 13.Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: 25 years of evaluation. Clin Psychol Ver. 1988;8:77–100. doi: 10.1016/0272-7358(88)90050-5. [DOI] [Google Scholar]
  • 14.Metzger D, DePhilippis D, Druley P, et al. The impact of HIV testing on risk for AIDS behaviors. NIDA Res Monogr. 1992;119:297–298. [Google Scholar]
  • 15.Metzger D, Woody G, McLellan A, et al. Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049–1056. [PubMed] [Google Scholar]
  • 16.Navaline HA, Snider EC, Petro C, et al. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses. 1994;10(2):12–12. [PubMed] [Google Scholar]
  • 17.Pechansky F, Soibelman M. In search of an explanatory model for exposure to HIV in a sample of drug users in Porto Alegre, Brazil.Building International Research on Drug Abuse—Nashville, Tennessee Meeting Highlights, Rockville, MD: National Institute on Drug Abuse.
  • 18.Pechansky F, Soibelman M, Kohlrausch E. Assessment of risk situations for HIV transmission among drug abusers in Porto Alegre, Brazil. J Drug Issues. 1997;27(1):147–154. [Google Scholar]
  • 19.Pechansky F, Metzger D, Hirakata V. Adaptation and validation of an AIDS questionnaire about risk behaviors for AIDS among drug users. Braz J Psychiatry. 2002;24(3):130–136. [Google Scholar]
  • 20.Daniel H, Parker R. Sexuality, Politics and Aids in Brazil. London, England: The Falmer Press; 1993. [Google Scholar]
  • 21.Santos B, Beck EJ, Peixoto MF. Survival and medical intervention in southern Brazilian AIDS patients. Int J STD AIDS. 1994;5:279–283. doi: 10.1177/095646249400500410. [DOI] [PubMed] [Google Scholar]
  • 22.Lima E, Friedman SR, Bastos FI, et al. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction. 1994;89:689–698. doi: 10.1111/j.1360-0443.1994.tb00955.x. [DOI] [PubMed] [Google Scholar]
  • 23.Telles PR, Bastos FI, Guydish J, et al. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS. 1997;11(suppl 1):S35–S42. [PubMed] [Google Scholar]
  • 24.Kalichman AO. AIDS and intravenous drug use in Brasil. In: Monteiro MG, Inciardi JA, editors. Brasil-United States Binational Research. Sao Paulo, Brazil: CEBRID; 1993. pp. 49–61. [Google Scholar]
  • 25.Pechansky F. Uhi estudo sobre situações de risco para contaminação pelo virus HIV em usuários de drogas da cidade de Porto Alegre. Rio Grande do Sul, Brazil: Postgraduate Program of Medical Clinics, Federal University of Rio Grande do Sul; 1998. [Google Scholar]
  • 26.Pechansky F, Inciardi J, Surratt H, et al. Estudo sobre as caracteristicas de usurios de drogas injetáveis que buscam atendimento em Porto Alegre, RS. Rev Bras Psiquiatr. 2002;22(4):164–171. [Google Scholar]
  • 27.Kleinman PH, Miller AB, Millman RB, et al. Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis. 1990;178(7):442–447. doi: 10.1097/00005053-199007000-00005. [DOI] [PubMed] [Google Scholar]
  • 28.Compton WM, Cottler LB, Phelps DL, Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict. 2000;9(2):126–134. doi: 10.1080/10550490050173190. [DOI] [PubMed] [Google Scholar]
  • 29.Inciardi JA, Surratt HL, McCoy HV. Establishing an HIV/AIDS intervention program for street drug users in a developing nation. J Drug Issues. 1997;27(1):173–193. [Google Scholar]
  • 30.Friedman SR, Jose B, Deren S, et al. Risk factors for human immunodeficiency virus seroconversion among out of treatment drug injectors in high and low prevalence cities. Am J Epidemiol. 1995;142:864–874. doi: 10.1093/oxfordjournals.aje.a117726. [DOI] [PubMed] [Google Scholar]
  • 31.Iguchi MY, Bux DA, Lidz V, et al. Changes in HIV risk behavior among injection drug users: the impact of 21 versus 90 days of methadone detoxification. AIDS. 1996;10:1719–1728. doi: 10.1097/00002030-199612000-00017. [DOI] [PubMed] [Google Scholar]
  • 32.Chitwood DD, McCoy CB, Comeford M, et al. The prevalence and incidence of HIV among injection drug users: a 5 year panel study. Popul Res Policy Rev. 1999;18:39–53. doi: 10.1023/A:1006148711071. [DOI] [Google Scholar]
  • 33.Ouellet LJ, Thorpe LE, Huo D, et al. Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994–1996. J Acquir Immune Defic Syndr. 2002;25(5):443–450. doi: 10.1097/00042560-200012150-00010. [DOI] [PubMed] [Google Scholar]
  • 34.Woody GE, Gallop R, Luborsky L, et al. HIV risk reduction in the NIDA cocaine psychotherapy study.J Acquir Immune Defic Syndr. In press. [DOI] [PubMed]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES